In vitro simulated pharmacokinetics profiles: forecasting antibiotic optimal dosage

Area of Science:

• Pharmacology
• Microbiology
• Drug kinetics

Background:

• Understanding antimicrobial effect (AME) kinetics is crucial for optimizing antibiotic therapy.
• Sisomicin (SMN) and cefotaxime (CTX) are important antibiotics with distinct pharmacokinetic profiles.
• Previous studies have focused on the relationship between antibiotic exposure (AUC) and efficacy, but the role of elimination rate is less understood.

Purpose of the Study:

• To investigate the influence of different elimination rates on the antimicrobial effect kinetics of sisomicin and cefotaxime in vitro.
• To determine if antibiotic efficacy is solely dependent on the area under the curve (AUC) or if pharmacokinetic profile nuances play a role.

Main Methods:

• Simulated in vitro pharmacokinetic profiles of SMN and CTX with normal and impaired elimination rates.
• Monitored antimicrobial effect (AME) intensity and duration in relation to drug concentration (AUC).
• Analyzed the appearance of bacteriostatic and bactericidal phases under varying drug elimination scenarios.

Main Results:

• The general shape of AME intensity/duration curves versus SMN and CTX AUC curves showed similar patterns, including bacteriostatic and bactericidal phases, regardless of elimination rate.
• However, AME versus AUC curves did not match when comparing simulated normal and delayed drug elimination.
• This indicates that AME is influenced by factors beyond just the AUC value.

Conclusions:

• Antibiotic efficient concentration is intrinsically linked to the pharmacokinetic profile, not solely defined by AUC.
• The rate of drug elimination significantly impacts the overall antimicrobial effect kinetics.
• These findings highlight the importance of considering individual pharmacokinetic variations for effective antibiotic dosing strategies.